Business Context and Reporting Period
Company: Perspective Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 1, 2025
Event: Update to corporate presentation (Item 8.01 Other Events).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the update of a corporate presentation and does not contain financial statements or specific financial data points.
Material Changes
No material financial changes versus the prior comparable period are reported in this document. The only disclosed event is the release of an updated corporate presentation.
Guidance, Outlook, and Risks
Management Commentary: The company updated its corporate presentation, which is filed as Exhibit 99.1. Specific details regarding guidance, outlook, risks, or contingencies are not included in the text of this 8-K filing; investors must refer to the attached presentation for such information.
Unusual Items: None reported.
Investor Verification Checklist
- Review Exhibit 99.1 (Corporate Presentation) for updated strategic outlook and financial projections.
- Verify the trading symbol (CATX) on NYSE American LLC.
- Confirm the company's status as an emerging growth company (not elected in this filing).
- Check for subsequent filings if the corporate presentation contains forward-looking statements requiring updates.